Insidervault
LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
Reporting ownerCIK 0001629383

Sarah Boyce

17 transactions in 3 companies, from December 17, 2025 to September 18, 2026.

Transactions
173 companies
Bought · P
$0open market
Sold · S
$1.7Mopen market
Net
−$1.7Mnet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Atrium Therapeutics, Inc.RNA8—$1.7M
Avidity Biosciences, Inc.RNAM8——
Contineum Therapeutics, Inc.CTNM1——

All transactions

17 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValue
Atrium Therapeutics, Inc.RNASarah BoyceDirSep 18F126,418$8.95$1.1M
Contineum Therapeutics, Inc.CTNMSarah BoyceDirDERIVJun 26A19,000$0.00—?
Atrium Therapeutics, Inc.RNASarah BoyceDirDERIVFeb 27A20,000$0.00—?
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D165,000——
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D300,000——
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D200,000——
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D400,000——
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D425,000——
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D300,000——
Avidity Biosciences, Inc.RNAMSarah BoyceCEODERIVFeb 27D386,015——
Avidity Biosciences, Inc.RNAMSarah BoyceCEOFeb 27D474,861——
Avidity Biosciences, Inc.RNASarah BoyceCEOJan 21SPLAN7,993$72.45$579K
Avidity Biosciences, Inc.RNASarah BoyceCEOJan 21SPLAN6,394$72.45$463K
Avidity Biosciences, Inc.RNASarah BoyceCEOJan 7SPLAN8,576$72.23$619K
Avidity Biosciences, Inc.RNASarah BoyceCEODec 18G29,159$0.00—
Avidity Biosciences, Inc.RNASarah BoyceCEODec 17F15,742$71.87$1.1M
Avidity Biosciences, Inc.RNASarah BoyceCEODec 17A31,000$0.00—